Faraz Ali

CEO

CFO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

TNYA

Current role

CEO, CFO, Board Member

2018-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Tenaya Therapeutics, Inc. (TNYA)	M.B.A. Chief Executive Officer Whittemore (Whit) Tingley, M.D., Ph.D.	$664,173	—	$141,924	$755,507	$319,275	$516	$1,881,396
2024	Tenaya Therapeutics, Inc. (TNYA)	M.B.A. Whittemore (Whit) Tingley, M.D., Ph.D.	$636,189	—	$443,700	$2,047,927	$153,450	$636	$3,281,901
2023	Tenaya Therapeutics, Inc. (TNYA)	M.B.A. Whittemore (Whit) Tingley, M.D., Ph.D.	$593,800	—	$382,500	$1,617,503	$293,931	$2,328	$2,890,062
2022	Tenaya Therapeutics, Inc. (TNYA)	M.B.A. Whittemore (Whit) Tingley, M.D., Ph.D.	$571,459	—	—	$4,751,013	$242,700	$2,228	$5,567,400
2021	Tenaya Therapeutics, Inc. (TNYA)	M.B.A.	$493,750	—	—	$4,259,989	$216,120	$896	$4,970,756
2020	Tenaya Therapeutics, Inc. (TNYA)	M.B.A.	$425,000	$126,500	—	$197,500	—	$1,300	$750,300

No earnings-call appearances or filed executive changes recorded yet.